Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives
Editat de Donald E. Goodkin, Richard A. Rudicken Limba Engleză Paperback – 26 mai 1998
Preț: 728.69 lei
Preț vechi: 767.05 lei
-5% Nou
Puncte Express: 1093
Preț estimativ în valută:
139.45€ • 145.05$ • 115.13£
139.45€ • 145.05$ • 115.13£
Carte tipărită la comandă
Livrare economică 14-28 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781852330330
ISBN-10: 1852330333
Pagini: 388
Ilustrații: XVIII, 364 p. 4 illus.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.74 kg
Ediția:Softcover reprint of the original 1st ed. 1996
Editura: SPRINGER LONDON
Colecția Springer
Locul publicării:London, United Kingdom
ISBN-10: 1852330333
Pagini: 388
Ilustrații: XVIII, 364 p. 4 illus.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.74 kg
Ediția:Softcover reprint of the original 1st ed. 1996
Editura: SPRINGER LONDON
Colecția Springer
Locul publicării:London, United Kingdom
Public țintă
ResearchCuprins
1 Recent Advances and Future Challenges in Multiple Sclerosis Clinical Trial Design.- 2 Pathogenesis of Multiple Sclerosis: Relationship to Therapeutic Strategies.- 3 Future of Multiple Sclerosis Therapeutics: Rational Approaches Targeting Putative Pathogenic Mechanisms.- 4 Statistical and Design Considerations for Multiple Sclerosis Clinical Trials.- 5 Clinical Outcome Measures for Multiple Sclerosis.- 6 Use of Neuropsychologic Outcome Measures in Multiple Sclerosis Clinical Trials: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design.- 7 “Quality of Life” Assessment in Multiple Sclerosis Clinical Trials: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design.- 8. Magnetic Resonance Imaging: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design.- 9. Magnetic Resonance Imaging of Patients with Isolated Idiopathic Optic Neuritis, Brainstem Syndromes and Myelopathy.- 10 Strategies to Delay the Onset of Clinically Definite Multiple Sclerosis in Patients with Monosymptomatic Presentations of Optic Neuritis, Brainstem Syndromes or Myelopathy.- 11 Treatment of Multiple Sclerosis with Type I Interferons.- 12 Treatment of Multiple Sclerosis with Methotrexate.- 13 Treatment of Multiple Sclerosis with Copolymer 1.- 14 Treatment of Multiple Sclerosis with Cladribine.- 15 Ethical Considerations Raised by Clinical Trials.- 16 The Emergence of Multiple Sclerosis as a “Treatable” Condition: An Historical Perspective.
Caracteristici
Covers the important new developments in clinical trial design and a number of important trial results that have resulted in new treatment options for patients and physicians * Important ethical considerations that arise with new treatments are included, as is a perspective on the emergence of MS as a treatable disease * Will be of interest to both specialists and general practitioners alike * Also will be of value to clinical epidemiologists and biostatisticians with an interest in experimental therapies for chronic disease, to immunologists with an interest in autoimmune disease, and to the pharmaceutical industry and to Multiple Sclerosis societies